Decoy Therapeutics Inc. Debt Securities, Available-for-sale, Realized Gain
Decoy Therapeutics Inc. (DCOY) reported Debt Securities, Available-for-sale, Realized Gain of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2019-03-06
- Decoy Therapeutics Inc. debt securities, available-for-sale, realized gain for fiscal 2018 was $0.00.
- Decoy Therapeutics Inc. debt securities, available-for-sale, realized gain for fiscal 2017 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |